Skip to content 
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada. more
| Oct '24 | Oct '25 | |||||
|---|---|---|---|---|---|---|
| Total Revenue | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
| Cost of Revenue | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
| Gross Profit | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
| Gross Margin | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
| Operating Expenses | 643.04K | 3.96M | [{"date":"2024-10-31","value":16.25,"profit":true},{"date":"2025-10-31","value":100,"profit":true}] | |||
| Operating Income | (643.04K) | (3.96M) | [{"date":"2024-10-31","value":-64304200,"profit":false},{"date":"2025-10-31","value":-395832900,"profit":false}] | |||
| Total Non-Operating Income/Expense | 171.18K | 34.77K | [{"date":"2024-10-31","value":100,"profit":true},{"date":"2025-10-31","value":20.31,"profit":true}] | |||
| Pre-Tax Income | (471.87K) | (3.92M) | [{"date":"2024-10-31","value":-47186700,"profit":false},{"date":"2025-10-31","value":-392355700,"profit":false}] | |||
| Income Taxes | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
| Income After Taxes | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
| Income From Continuous Operations | (471.87K) | (3.92M) | [{"date":"2024-10-31","value":-47186700,"profit":false},{"date":"2025-10-31","value":-392355700,"profit":false}] | |||
| Income From Discontinued Operations | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
| Net Income | (471.87K) | (3.92M) | [{"date":"2024-10-31","value":-47186700,"profit":false},{"date":"2025-10-31","value":-392355700,"profit":false}] | |||
| EPS (Diluted) | - | - | [{"date":"2024-10-31","value":"-","profit":true},{"date":"2025-10-31","value":"-","profit":true}] | |||
These ratios help you determine the liquidity of the company. Higher is better.
| CNXU | |
|---|---|
| Current Ratio | 8.51 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| CNXU | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| CNXU | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.11 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.89 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| CNXU | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 35.93 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Conexeu Sciences Inc. Common Stock (CNXU) share price today is $15.652
Yes, Indians can buy shares of Conexeu Sciences Inc. Common Stock (CNXU) on Vested. To buy
Yes, you can purchase fractional shares of Conexeu Sciences Inc. Common Stock (CNXU) via the Vested app. You can start investing in Conexeu Sciences Inc. Common Stock (CNXU) with a minimum investment of $1.
You can invest in shares of Conexeu Sciences Inc. Common Stock (CNXU) via Vested in three simple steps:
The 52-week high price of Conexeu Sciences Inc. Common Stock (CNXU) is $17.5. The 52-week low price of Conexeu Sciences Inc. Common Stock (CNXU) is $10.87.
The price-to-earnings (P/E) ratio of Conexeu Sciences Inc. Common Stock (CNXU) is
The price-to-book (P/B) ratio of Conexeu Sciences Inc. Common Stock (CNXU) is 35.93
The dividend yield of Conexeu Sciences Inc. Common Stock (CNXU) is 0.00%
The market capitalization of Conexeu Sciences Inc. Common Stock (CNXU) is $245.24M
The stock symbol (or ticker) of Conexeu Sciences Inc. Common Stock is CNXU
Consider the share price of Conexeu Sciences Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Conexeu Sciences Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Conexeu Sciences Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Conexeu Sciences Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Conexeu Sciences Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Conexeu Sciences Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
